Sympathetic Ophthalmia: Incidence of Ocular Complications and Vision Loss in the Sympathizing Eye

Anat Galor, Janet L Davis, Harry W Flynn, William J Feuer, Sander Dubovy, Vikram Setlur, Muge R. Kesen, Debra A. Goldstein, Howard H. Tessler, Irina Bykhovskaya Ganelis, Douglas A. Jabs, Jennifer E. Thorne

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Purpose: To report the frequency on presentation and subsequent incidence of ocular complications and vision loss in patients with sympathetic ophthalmia (SO) and to describe factors associated with decreased vision in the sympathizing eye. Design: Multicenter retrospective case series. Methods: setting: Three academic tertiary care uveitis clinics. study population: Eighty-five patients with SO from 1976 to 2006. observation procedures: Review of existing medical records. main outcome measures: Incident visual acuity (VA) loss to 20/50 or worse and 20/200 or worse and the median acuity over time. Results: Twenty-six percent of patients with SO presented with a VA of 20/200 or worse in their sympathizing eye. Further development of vision loss to 20/200 or worse occurred at the rate of 10% per person-year (PY). Ocular complications were seen in the sympathizing eye in 47% of patients at presentation; further development of new complications occurred at the rate of 40%/PY. The ocular complications most often associated with decreased vision were cataract and optic nerve abnormality. Exudative retinal detachment and active intraocular inflammation were significantly associated with poorer VA in the sympathizing eye. The benefits of corticosteroids were indirectly demonstrated as their use led to more rapid disease inactivation. Fifty-nine percent of patients maintained a VA of better than 20/50 in their sympathizing eye; and 75% maintained a VA of better than 20/200. Conclusions: Although ocular complications were seen in many sympathizing eyes with SO, most patients maintained functional VA. The presence of an exudative retinal detachment and active intraocular inflammation correlated with poorer vision in the sympathizing eye.

Original languageEnglish
JournalAmerican Journal of Ophthalmology
Volume148
Issue number5
DOIs
StatePublished - Nov 1 2009

Fingerprint

Sympathetic Ophthalmia
Incidence
Visual Acuity
Retinal Detachment
Inflammation
Uveitis
Tertiary Healthcare
Optic Nerve
Cataract
Medical Records
Adrenal Cortex Hormones

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Sympathetic Ophthalmia : Incidence of Ocular Complications and Vision Loss in the Sympathizing Eye. / Galor, Anat; Davis, Janet L; Flynn, Harry W; Feuer, William J; Dubovy, Sander; Setlur, Vikram; Kesen, Muge R.; Goldstein, Debra A.; Tessler, Howard H.; Ganelis, Irina Bykhovskaya; Jabs, Douglas A.; Thorne, Jennifer E.

In: American Journal of Ophthalmology, Vol. 148, No. 5, 01.11.2009.

Research output: Contribution to journalArticle

Galor, Anat ; Davis, Janet L ; Flynn, Harry W ; Feuer, William J ; Dubovy, Sander ; Setlur, Vikram ; Kesen, Muge R. ; Goldstein, Debra A. ; Tessler, Howard H. ; Ganelis, Irina Bykhovskaya ; Jabs, Douglas A. ; Thorne, Jennifer E. / Sympathetic Ophthalmia : Incidence of Ocular Complications and Vision Loss in the Sympathizing Eye. In: American Journal of Ophthalmology. 2009 ; Vol. 148, No. 5.
@article{17b56ee19fba434ea390df07d4df19ea,
title = "Sympathetic Ophthalmia: Incidence of Ocular Complications and Vision Loss in the Sympathizing Eye",
abstract = "Purpose: To report the frequency on presentation and subsequent incidence of ocular complications and vision loss in patients with sympathetic ophthalmia (SO) and to describe factors associated with decreased vision in the sympathizing eye. Design: Multicenter retrospective case series. Methods: setting: Three academic tertiary care uveitis clinics. study population: Eighty-five patients with SO from 1976 to 2006. observation procedures: Review of existing medical records. main outcome measures: Incident visual acuity (VA) loss to 20/50 or worse and 20/200 or worse and the median acuity over time. Results: Twenty-six percent of patients with SO presented with a VA of 20/200 or worse in their sympathizing eye. Further development of vision loss to 20/200 or worse occurred at the rate of 10{\%} per person-year (PY). Ocular complications were seen in the sympathizing eye in 47{\%} of patients at presentation; further development of new complications occurred at the rate of 40{\%}/PY. The ocular complications most often associated with decreased vision were cataract and optic nerve abnormality. Exudative retinal detachment and active intraocular inflammation were significantly associated with poorer VA in the sympathizing eye. The benefits of corticosteroids were indirectly demonstrated as their use led to more rapid disease inactivation. Fifty-nine percent of patients maintained a VA of better than 20/50 in their sympathizing eye; and 75{\%} maintained a VA of better than 20/200. Conclusions: Although ocular complications were seen in many sympathizing eyes with SO, most patients maintained functional VA. The presence of an exudative retinal detachment and active intraocular inflammation correlated with poorer vision in the sympathizing eye.",
author = "Anat Galor and Davis, {Janet L} and Flynn, {Harry W} and Feuer, {William J} and Sander Dubovy and Vikram Setlur and Kesen, {Muge R.} and Goldstein, {Debra A.} and Tessler, {Howard H.} and Ganelis, {Irina Bykhovskaya} and Jabs, {Douglas A.} and Thorne, {Jennifer E.}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.ajo.2009.05.033",
language = "English",
volume = "148",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Sympathetic Ophthalmia

T2 - Incidence of Ocular Complications and Vision Loss in the Sympathizing Eye

AU - Galor, Anat

AU - Davis, Janet L

AU - Flynn, Harry W

AU - Feuer, William J

AU - Dubovy, Sander

AU - Setlur, Vikram

AU - Kesen, Muge R.

AU - Goldstein, Debra A.

AU - Tessler, Howard H.

AU - Ganelis, Irina Bykhovskaya

AU - Jabs, Douglas A.

AU - Thorne, Jennifer E.

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Purpose: To report the frequency on presentation and subsequent incidence of ocular complications and vision loss in patients with sympathetic ophthalmia (SO) and to describe factors associated with decreased vision in the sympathizing eye. Design: Multicenter retrospective case series. Methods: setting: Three academic tertiary care uveitis clinics. study population: Eighty-five patients with SO from 1976 to 2006. observation procedures: Review of existing medical records. main outcome measures: Incident visual acuity (VA) loss to 20/50 or worse and 20/200 or worse and the median acuity over time. Results: Twenty-six percent of patients with SO presented with a VA of 20/200 or worse in their sympathizing eye. Further development of vision loss to 20/200 or worse occurred at the rate of 10% per person-year (PY). Ocular complications were seen in the sympathizing eye in 47% of patients at presentation; further development of new complications occurred at the rate of 40%/PY. The ocular complications most often associated with decreased vision were cataract and optic nerve abnormality. Exudative retinal detachment and active intraocular inflammation were significantly associated with poorer VA in the sympathizing eye. The benefits of corticosteroids were indirectly demonstrated as their use led to more rapid disease inactivation. Fifty-nine percent of patients maintained a VA of better than 20/50 in their sympathizing eye; and 75% maintained a VA of better than 20/200. Conclusions: Although ocular complications were seen in many sympathizing eyes with SO, most patients maintained functional VA. The presence of an exudative retinal detachment and active intraocular inflammation correlated with poorer vision in the sympathizing eye.

AB - Purpose: To report the frequency on presentation and subsequent incidence of ocular complications and vision loss in patients with sympathetic ophthalmia (SO) and to describe factors associated with decreased vision in the sympathizing eye. Design: Multicenter retrospective case series. Methods: setting: Three academic tertiary care uveitis clinics. study population: Eighty-five patients with SO from 1976 to 2006. observation procedures: Review of existing medical records. main outcome measures: Incident visual acuity (VA) loss to 20/50 or worse and 20/200 or worse and the median acuity over time. Results: Twenty-six percent of patients with SO presented with a VA of 20/200 or worse in their sympathizing eye. Further development of vision loss to 20/200 or worse occurred at the rate of 10% per person-year (PY). Ocular complications were seen in the sympathizing eye in 47% of patients at presentation; further development of new complications occurred at the rate of 40%/PY. The ocular complications most often associated with decreased vision were cataract and optic nerve abnormality. Exudative retinal detachment and active intraocular inflammation were significantly associated with poorer VA in the sympathizing eye. The benefits of corticosteroids were indirectly demonstrated as their use led to more rapid disease inactivation. Fifty-nine percent of patients maintained a VA of better than 20/50 in their sympathizing eye; and 75% maintained a VA of better than 20/200. Conclusions: Although ocular complications were seen in many sympathizing eyes with SO, most patients maintained functional VA. The presence of an exudative retinal detachment and active intraocular inflammation correlated with poorer vision in the sympathizing eye.

UR - http://www.scopus.com/inward/record.url?scp=70350457017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350457017&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2009.05.033

DO - 10.1016/j.ajo.2009.05.033

M3 - Article

C2 - 19665105

AN - SCOPUS:70350457017

VL - 148

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -